373 related articles for article (PubMed ID: 27586019)
1. QbD based development of proliposome of lopinavir for improved oral bioavailability.
Patel GM; Shelat PK; Lalwani AN
Eur J Pharm Sci; 2017 Oct; 108():50-61. PubMed ID: 27586019
[TBL] [Abstract][Full Text] [Related]
2. Systematic development of solid self-nanoemulsifying oily formulations (S-SNEOFs) for enhancing the oral bioavailability and intestinal lymphatic uptake of lopinavir.
Garg B; Katare OP; Beg S; Lohan S; Singh B
Colloids Surf B Biointerfaces; 2016 May; 141():611-622. PubMed ID: 26916320
[TBL] [Abstract][Full Text] [Related]
3. Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment.
Patel G; Shelat P; Lalwani A
Drug Deliv; 2016 Oct; 23(8):3027-3042. PubMed ID: 26882014
[TBL] [Abstract][Full Text] [Related]
4. Development and in vivo evaluation of child-friendly lopinavir/ritonavir pediatric granules utilizing novel in situ self-assembly nanoparticles.
Pham K; Li D; Guo S; Penzak S; Dong X
J Control Release; 2016 Mar; 226():88-97. PubMed ID: 26849919
[TBL] [Abstract][Full Text] [Related]
5. A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation.
Ravi PR; Vats R; Dalal V; Murthy AN
J Pharm Pharmacol; 2014 Jul; 66(7):912-26. PubMed ID: 24697749
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable nanoparticles from prosopisylated cellulose as a platform for enhanced oral bioavailability of poorly water-soluble drugs.
Kenechukwu FC; Dias ML; Ricci-Júnior E
Carbohydr Polym; 2021 Mar; 256():117492. PubMed ID: 33483021
[TBL] [Abstract][Full Text] [Related]
7. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
8. QbD-based systematic development of novel optimized solid self-nanoemulsifying drug delivery systems (SNEDDS) of lovastatin with enhanced biopharmaceutical performance.
Beg S; Sandhu PS; Batra RS; Khurana RK; Singh B
Drug Deliv; 2015; 22(6):765-84. PubMed ID: 24673611
[TBL] [Abstract][Full Text] [Related]
9. Surface-stabilized lopinavir nanoparticles enhance oral bioavailability without coadministration of ritonavir.
Jain S; Sharma JM; Jain AK; Mahajan RR
Nanomedicine (Lond); 2013 Oct; 8(10):1639-55. PubMed ID: 23351133
[TBL] [Abstract][Full Text] [Related]
10. Design, optimization and evaluation of poly-ε-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir.
Ravi PR; Vats R; Dalal V; Gadekar N; N A
Drug Dev Ind Pharm; 2015 Jan; 41(1):131-40. PubMed ID: 24180260
[TBL] [Abstract][Full Text] [Related]
11. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
[TBL] [Abstract][Full Text] [Related]
12. Design of novel proliposome formulation for antioxidant peptide, glutathione with enhanced oral bioavailability and stability.
Byeon JC; Lee SE; Kim TH; Ahn JB; Kim DH; Choi JS; Park JS
Drug Deliv; 2019 Dec; 26(1):216-225. PubMed ID: 30843439
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study.
Zeng C; Jiang W; Tan M; Yang X; He C; Huang W; Xing J
Eur J Pharm Sci; 2016 Mar; 85():123-31. PubMed ID: 26883760
[TBL] [Abstract][Full Text] [Related]
14. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine.
Nekkanti V; Rueda J; Wang Z; Betageri GV
Int J Pharm; 2016 May; 505(1-2):79-88. PubMed ID: 27041124
[TBL] [Abstract][Full Text] [Related]
16. Solid self-microemulsifying drug delivery system of ritonavir.
Deshmukh A; Kulkarni S
Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049
[TBL] [Abstract][Full Text] [Related]
17. Exploring the potential of self-assembled mixed micelles in enhancing the stability and oral bioavailability of an acid-labile drug.
Zhang X; Wang H; Zhang T; Zhou X; Wu B
Eur J Pharm Sci; 2014 Oct; 62():301-8. PubMed ID: 24956461
[TBL] [Abstract][Full Text] [Related]
18. Nanocapsules embedded in microparticles for enhanced oral bioavailability and efficacy of Lopinavir as an anti-AIDS drug.
Nassar T; Rohald A; Naraykin N; Barasch D; Amsalem O; Prabhu P; Kotler M; Benita S
J Drug Target; 2019; 27(5-6):590-600. PubMed ID: 30470150
[TBL] [Abstract][Full Text] [Related]
19. QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.
Beg S; Saini S; Bandopadhyay S; Katare OP; Singh B
Drug Dev Ind Pharm; 2018 Mar; 44(3):407-420. PubMed ID: 29048242
[TBL] [Abstract][Full Text] [Related]
20. Novel bicephalous heterolipid based self-microemulsifying drug delivery system for solubility and bioavailability enhancement of efavirenz.
Chaudhari KS; Akamanchi KG
Int J Pharm; 2019 Apr; 560():205-218. PubMed ID: 30742985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
